AAPG/ 01/07/2026 · 9:01 AM Ascentage Pharma's New Cancer Drug Gets FDA Green Light for Clinical Trials Ascentage Pharma receives FDA clearance for APG-3288, an innovative BTK protein degrader designed to treat resistant blood cancers through a novel degradation approach.